ATE515268T1 - Verwendung von op-1 zur behandlung von knorpeldefekten - Google Patents
Verwendung von op-1 zur behandlung von knorpeldefektenInfo
- Publication number
- ATE515268T1 ATE515268T1 AT05753766T AT05753766T ATE515268T1 AT E515268 T1 ATE515268 T1 AT E515268T1 AT 05753766 T AT05753766 T AT 05753766T AT 05753766 T AT05753766 T AT 05753766T AT E515268 T1 ATE515268 T1 AT E515268T1
- Authority
- AT
- Austria
- Prior art keywords
- cartilage defects
- treat cartilage
- cartilage
- treat
- repairing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57442304P | 2004-05-25 | 2004-05-25 | |
PCT/US2005/018020 WO2005115438A1 (en) | 2004-05-25 | 2005-05-24 | Use of morphogenic proteins for treating cartilage defects |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE515268T1 true ATE515268T1 (de) | 2011-07-15 |
Family
ID=34970831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05753766T ATE515268T1 (de) | 2004-05-25 | 2005-05-24 | Verwendung von op-1 zur behandlung von knorpeldefekten |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP2298335B1 (de) |
JP (4) | JP5201987B2 (de) |
AT (1) | ATE515268T1 (de) |
AU (1) | AU2005247440B2 (de) |
CA (1) | CA2567405A1 (de) |
ES (1) | ES2369629T3 (de) |
WO (1) | WO2005115438A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169405B2 (en) | 2003-08-06 | 2007-01-30 | Warsaw Orthopedic, Inc. | Methods and devices for the treatment of intervertebral discs |
US20060194726A1 (en) * | 2004-05-25 | 2006-08-31 | Rueger David C | Methods of treating cartilage defects |
US7771414B2 (en) | 2006-04-24 | 2010-08-10 | Warsaw Orthopedic, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
US8642059B2 (en) | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for intervertebral discs |
US8642060B2 (en) | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
US7879027B2 (en) | 2006-04-24 | 2011-02-01 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
WO2007142818A2 (en) * | 2006-05-17 | 2007-12-13 | Stryker Corporation | Use of a soluble morphogenic protein complex for treating cartilage defects |
RS52706B (en) * | 2006-10-06 | 2013-08-30 | Scil Technology Gmbh | FORMATION OF DRIED RECONSTITUTED VESICULES FOR PHARMACEUTICAL APPLICATION |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
EP2120859B1 (de) * | 2006-12-21 | 2013-11-20 | Stryker Corporation | Formulierungen mit verzögerter freisetzung mit kristallen von bmp-7 |
WO2008101300A1 (en) * | 2007-02-23 | 2008-08-28 | Cellixe Pty Ltd | Composition and method for the treatment or prevention of spinal disorders |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
WO2009020744A1 (en) | 2007-08-07 | 2009-02-12 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations comprising gdf-5 in aqueous acidic solution |
CA2714506C (en) * | 2008-02-08 | 2016-06-07 | Qps Llc | Composition for sustained release delivery of proteins or peptides |
WO2009129101A1 (en) | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
CN102369017A (zh) | 2009-02-12 | 2012-03-07 | 史赛克公司 | 用于微创系统性递送包含TGF-β超家族成员的蛋白质的组合物和方法 |
CA2774024A1 (en) | 2009-09-17 | 2011-03-24 | Stryker Corporation | Buffers for controlling the ph of bone morphogenetic proteins |
US9132207B2 (en) | 2009-10-27 | 2015-09-15 | Spine Wave, Inc. | Radiopaque injectable nucleus hydrogel compositions |
JP2013514811A (ja) | 2009-12-22 | 2013-05-02 | ストライカー コーポレイション | 免疫原性が抑制されたbmp−7変異体 |
WO2017203331A1 (en) | 2016-05-27 | 2017-11-30 | Universität Bern | Composition and methods for bone tissue engineering |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773319A (en) | 1971-12-16 | 1973-11-20 | Fabcor Ind Inc | Corrugated sheet inverting machine |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US5354557A (en) | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
US5266683A (en) | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US5324819A (en) | 1988-04-08 | 1994-06-28 | Stryker Corporation | Osteogenic proteins |
ATE162223T1 (de) | 1989-03-28 | 1998-01-15 | Genetics Inst | Osteoinduktive zusammensetzungen |
JP3504259B2 (ja) * | 1989-03-28 | 2004-03-08 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 骨誘導組成物 |
ES2168091T3 (es) | 1990-05-16 | 2002-06-01 | Genetics Inst | Proteinas de induccion osea y cartilaginosa. |
ATE184052T1 (de) | 1990-06-15 | 1999-09-15 | Carnegie Inst Of Washington | Gdf-1 und uog1 proteine |
US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
DK0592562T3 (da) | 1991-06-25 | 1999-08-30 | Genetics Inst | BMP-9-præparater |
EP0625989B1 (de) | 1992-02-12 | 2000-01-19 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren |
WO1994010203A2 (en) | 1992-11-03 | 1994-05-11 | Creative Biomolecules, Inc. | Op-3-induced morphogenesis |
EP0690871A4 (de) | 1993-01-12 | 1999-10-20 | Univ Johns Hopkins Med | Wachstums-differenzierungsfaktor-5 |
JP3482207B2 (ja) | 1993-01-12 | 2003-12-22 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | 増殖分化因子−9 |
EP1333035A3 (de) | 1993-03-19 | 2004-07-07 | The Johns Hopkins University School Of Medicine | Wachstumsdifferenzierungsfaktor-8 |
ES2213745T3 (es) | 1993-05-12 | 2004-09-01 | Genetics Institute, Llc | Composiciones de bmp-11. |
EP0698095B1 (de) | 1993-05-12 | 2004-04-28 | Genetics Institute, LLC | Bmp-10 zusammensetzungen |
AU697625B2 (en) | 1993-07-09 | 1998-10-15 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-6 |
JPH0788174A (ja) * | 1993-09-28 | 1995-04-04 | Yamanouchi Pharmaceut Co Ltd | 骨形成用移植体 |
EP1559726A3 (de) | 1993-10-08 | 2006-01-25 | The Johns Hopkins University School Of Medicine | Wachstumsdifferenzierungsfaktor-10 |
DE4334646C1 (de) | 1993-10-12 | 1994-09-29 | Quinting Friedhelm | Durchsichtige Analog-Zeituhr |
JP3300500B2 (ja) | 1993-10-12 | 2002-07-08 | 新日本製鐵株式会社 | 疲労強度、降伏強度および被削性に優れる熱間鍛造用鋼の製造方法 |
PT733109E (pt) | 1993-12-07 | 2006-07-31 | Genetics Inst Llc | Proteinas morfogeneticas dos 0ss0s pmo-12 e pmo-13 e as suas composicoes para inducao de tendao |
IL114397A0 (en) | 1994-07-01 | 1995-10-31 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF-beta-family |
EP1574577A3 (de) | 1994-07-08 | 2006-06-14 | The Johns Hopkins University School Of Medicine | Wachstums-Differenzierungsfaktor-11 |
AU1120295A (en) * | 1994-11-07 | 1996-05-31 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cartilage-derived morphogenetic proteins |
US5635372A (en) | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
US5902785A (en) * | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
US5674292A (en) * | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
US6281195B1 (en) * | 1997-02-07 | 2001-08-28 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
US6027917A (en) | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
EP1095159A4 (de) * | 1998-07-15 | 2003-01-02 | Human Genome Sciences Inc | Knochenmorphogenese-protein |
CA2343698C (en) * | 1998-10-06 | 2014-05-20 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US6958149B2 (en) * | 1998-10-06 | 2005-10-25 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
ATE255920T1 (de) * | 1999-02-01 | 2003-12-15 | Genetics Inst Llc | Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln |
DK1244388T3 (da) * | 1999-12-06 | 2007-05-14 | Warsaw Orthopedic Inc | Indretning til behandling af mellemhvirvelskiver |
JP2004521128A (ja) * | 2001-02-23 | 2004-07-15 | ワイス | Bmpによるヒト骨髄由来cd105+細胞の軟骨形成能 |
WO2003063799A2 (en) * | 2002-02-01 | 2003-08-07 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
EP1485487A4 (de) * | 2002-03-12 | 2005-11-09 | Tissuegene Inc | Knorpelregeneration mit chondrozyt und tgf-beta |
WO2003094617A2 (en) * | 2002-05-06 | 2003-11-20 | Genentech, Inc. | Use of vegf for treating bone defects |
JP2003325657A (ja) * | 2002-05-13 | 2003-11-18 | Hideki Yoshikawa | 関節軟骨形成用部材およびその製造方法、関節軟骨の再生または形成方法および培養方法ならびに移植用人工関節軟骨 |
US8154581B2 (en) | 2002-10-15 | 2012-04-10 | Revolutionary Concepts, Inc. | Audio-video communication system for receiving person at entrance |
JPWO2010117047A1 (ja) | 2009-04-10 | 2012-10-18 | 株式会社ニコン | 光学材料、光学素子、及びその製造方法 |
JP2011211450A (ja) | 2010-03-30 | 2011-10-20 | Victor Co Of Japan Ltd | 立体映像表示装置、立体映像撮像装置および立体映像表示方法 |
US9507084B2 (en) | 2010-12-03 | 2016-11-29 | Ofs Fitel, Llc | Single-mode, bend-compensated, large-mode-area optical fibers designed to accomodate simplified fabrication and tighter bends |
US8743666B1 (en) | 2011-03-08 | 2014-06-03 | Western Digital Technologies, Inc. | Energy assisted magnetic recording medium capable of suppressing high DC readback noise |
KR101851912B1 (ko) | 2012-06-07 | 2018-04-24 | 아사히 가세이 일렉트로닉스 가부시끼가이샤 | 위치 검출 장치 |
US9298469B2 (en) | 2012-06-15 | 2016-03-29 | International Business Machines Corporation | Management of multiple nested transactions |
US9405290B1 (en) | 2013-01-17 | 2016-08-02 | Kla-Tencor Corporation | Model for optical dispersion of high-K dielectrics including defects |
JP6154215B2 (ja) | 2013-06-28 | 2017-06-28 | 株式会社日立国際電気 | 半導体装置の製造方法、基板処理装置およびプログラム |
US9170581B2 (en) | 2013-09-30 | 2015-10-27 | Crown Equipment Limited | Industrial vehicles with overhead light based localization |
JP6541301B2 (ja) | 2014-03-28 | 2019-07-10 | キヤノン株式会社 | ロボット装置、ロボット装置の制御方法、ロボット制御プログラム、及び記録媒体 |
US9411440B2 (en) | 2014-08-22 | 2016-08-09 | Qualcomm Incorporated | Digital ultrasonic emitting base station |
US9400685B1 (en) | 2015-01-30 | 2016-07-26 | Huawei Technologies Co., Ltd. | Dividing, scheduling, and parallel processing compiled sub-tasks on an asynchronous multi-core processor |
-
2005
- 2005-05-24 WO PCT/US2005/018020 patent/WO2005115438A1/en active Application Filing
- 2005-05-24 EP EP10179674.6A patent/EP2298335B1/de not_active Not-in-force
- 2005-05-24 AU AU2005247440A patent/AU2005247440B2/en not_active Ceased
- 2005-05-24 JP JP2007515221A patent/JP5201987B2/ja not_active Expired - Fee Related
- 2005-05-24 AT AT05753766T patent/ATE515268T1/de not_active IP Right Cessation
- 2005-05-24 EP EP05753766A patent/EP1763362B1/de not_active Not-in-force
- 2005-05-24 ES ES05753766T patent/ES2369629T3/es active Active
- 2005-05-24 CA CA002567405A patent/CA2567405A1/en not_active Abandoned
-
2011
- 2011-07-04 JP JP2011148712A patent/JP2011189200A/ja not_active Withdrawn
-
2013
- 2013-07-19 JP JP2013150201A patent/JP2013213067A/ja active Pending
-
2016
- 2016-01-04 JP JP2016000286A patent/JP2016047855A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2005247440A1 (en) | 2005-12-08 |
ES2369629T3 (es) | 2011-12-02 |
JP2013213067A (ja) | 2013-10-17 |
EP1763362B1 (de) | 2011-07-06 |
CA2567405A1 (en) | 2005-12-08 |
EP1763362A1 (de) | 2007-03-21 |
JP2011189200A (ja) | 2011-09-29 |
EP2298335B1 (de) | 2014-09-03 |
JP5201987B2 (ja) | 2013-06-05 |
EP2298335A1 (de) | 2011-03-23 |
JP2008500346A (ja) | 2008-01-10 |
WO2005115438B1 (en) | 2006-01-05 |
AU2005247440B2 (en) | 2011-09-29 |
WO2005115438A1 (en) | 2005-12-08 |
JP2016047855A (ja) | 2016-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE515268T1 (de) | Verwendung von op-1 zur behandlung von knorpeldefekten | |
DE60137430D1 (de) | Gewebeimplant zur wiederherstellung von knorpelgewebe | |
DE602006018583D1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
ATE497778T1 (de) | Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus | |
DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
DK1615952T3 (da) | Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler | |
ATE493433T1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
DE602005019144D1 (de) | Verfahren zur schmerzbehandlung in knochenkrebs du | |
ATE404188T1 (de) | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten | |
DE602005011656D1 (de) | Verfahren zur behandlung von dickdarmkrebs mit botulinum neurotoxin | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
ATE395871T1 (de) | Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen | |
ATE362363T1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
ATE429645T1 (de) | Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten | |
DE60335293D1 (de) | Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen | |
ATE439863T1 (de) | Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie | |
ATE482722T1 (de) | Therapeutische verwendung von anti-cs1- antikörpern | |
DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
ATE308880T1 (de) | Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung | |
ATE540129T1 (de) | Target zur therapie kognitiver behinderungen | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
ATE485517T1 (de) | Verfahren zur identifizierung von polypeptid- targets | |
WO2007061924A3 (en) | Methods of treating cartilage defects | |
DE602006009786D1 (de) | Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten | |
DE602004017283D1 (de) | Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |